No More Free Drug Samples?
Authors:
Open Access
- 12 May 2009
- journal article
- essay
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 6 (5) , e1000074
Abstract
Susan Chimonas and Jerome Kassirer argue that giving out “free” drug samples is not effective in improving drug access for the indigent, does not promote rational drug use, and raises the cost of care.Keywords
This publication has 17 references indexed in Scilit:
- Free Drug Samples in the United States: Characteristics of Pediatric Recipients and Safety ConcernsPediatrics, 2008
- Characteristics of Patients Receiving Pharmaceutical Samples and Association Between Sample Receipt and Out-of-Pocket Prescription CostsMedical Care, 2008
- Characteristics of Recipients of Free Prescription Drug Samples: A Nationally Representative AnalysisAmerican Journal of Public Health, 2008
- The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United StatesPLOS Medicine, 2008
- Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.2007
- Interactions of doctors with the pharmaceutical industryJournal of Medical Ethics, 2006
- Do drug samples influence resident prescribing behavior? A randomized trialThe American Journal of Medicine, 2005
- Failing the Public Health — Rofecoxib, Merck, and the FDANew England Journal of Medicine, 2004
- A physician survey of the effect of drug sample availability on physicians’ behaviorJournal of General Internal Medicine, 2000
- The role of commercial sources in the adoption of a new drugSocial Science & Medicine, 1988